Last edition
News about "commercial manufacturing "
WuXi Biologics Receives Brazil GMP Certification for Cancer Therapy Manufacturing
WuXi Biologics has received Brazil ANVISA GMP certification with zero inspection findings, enabling global commercial manufacturing of its innovative cancer immunotherapy.
Commercial Manufacturing | 02/07/2026 | By News Bureau
Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.
Commercial Manufacturing | 12/03/2026 | By News Bureau | 126
AsymBio Begins Operations at Fengxian Base to Boost Global CDMO Capacity
AsymBio has commenced commercial operations at its 130,000-square-metre Fengxian base, adding a major hub to its global CDMO network alongside its Shanghai Jinshan and Zhangjiang facilities. The new site is built to offer flexible, scalable support across all clinical phases, delivering customised CDMO solutions.
Commercial Manufacturing | 08/12/2025 | By Dineshwori | 186
EUROAPI and Priothera to Advance Oncology Project
EUROAPI has begun the implementation of a 5-year development and manufacturing agreement with Priothera, a biotechnology company specializing in molecules for the treatment of hematological malignancies and for the improvement of CAR-T cell therapies.
Commercial Manufacturing | 20/06/2024 | By Aishwarya | 540
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy